progression-free survival

You have access
Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI)
TOMOHIRO TAMURA, TAKESHI NUMATA, HIDETOSHI YANAI, RYOTA NAKAMURA, TOSHIHIRO SHIOZAWA, HIROKO WATANABE, SHINICHIRO OKAUCHI, NORIHIRO KIKUCHI, KUNIHIKO MIYAZAKI, SHIGEN HAYASHI, TAKAAKI YAMASHITA, KOICHI KURISHIMA, MASAHARU INAGAKI, HIROAKI SATOH, HIROICHI ISHIKAWA, TAKAYUKI KABURAGI, TAKEO ENDO, TORU SAKAMOTO and NOBUYUKI HIZAWA

Anticancer Research October 2023, 43 (10) 4583-4591; DOI: https://doi.org/10.21873/anticanres.16652
You have access
Association Between the Severity of Immune-related Adverse Events and the Prognosis in Patients With Non-small Cell Lung Cancer Receiving Treatment With Immune Checkpoint Inhibitors
MINEHIKO INOMATA, MASAHIRO MATSUMOTO, KANA HAYASHI, ZENTA SETO, TAKAHIRO HIRAI, KOTARO TOKUI, CHIHIRO TAKA, SEISUKE OKAZAWA, KENTA KAMBARA, SHINGO IMANISHI, TOSHIRO MIWA, RYUJI HAYASHI, SHOKO MATSUI and KAZUYUKI TOBE

Anticancer Research July 2023, 43 (7) 3241-3246; DOI: https://doi.org/10.21873/anticanres.16498
Open Access
Autologous and Allogeneic Stem Cell Transplantation as Salvage Treatment Options for Relapsed/Refractory Multiple Myeloma: A Single-center Experience over 20 Years
NORMANN STEINER, PAULA SCHOBER, WOLFGANG WILLENBACHER, BRIGITTE KIRCHER, EBERHARD GUNSILIUS, DOMINIK WOLF and DAVID NACHBAUR

Anticancer Research December 2022, 42 (12) 5825-5832; DOI: https://doi.org/10.21873/anticanres.16090
You have access
Comparison of Survival Outcomes Based on Pre-treatment Pleural Effusion in Advanced Epithelial Ovarian Cancer
JUHUN LEE and DAE GY HONG

Anticancer Research October 2022, 42 (10) 4937-4943; DOI: https://doi.org/10.21873/anticanres.16000
You have access
A Real-world Multicenter Prospective Study of Everolimus in Pancreatic Neuroendocrine Tumors: The ‘PROTOR’ Study
GREGORY KALTSAS, CHARALAMBOS ANDREADIS, PARASKEVAS KOSMIDIS, DIMITRIOS MAVROUDIS, KALLIOPI PAZAITOU-PANAYIOTOU, MICHAIL VASLAMATZIS and ILIAS ATHANASIADIS

Anticancer Research April 2022, 42 (4) 1941-1948; DOI: https://doi.org/10.21873/anticanres.15672
You have access
Differences in Patterns of Recurrence Between Primary and Interval Debulking Surgery for Advanced Ovarian Cancer
VASILEIOS MITSOPOULOS, ANNI INNAMAA, JONATHAN LIPPIATT, SARAH COLLINS and IOANNIS BILIATIS

Anticancer Research April 2022, 42 (4) 2003-2008; DOI: https://doi.org/10.21873/anticanres.15679
You have access
Utility of Follow-up With Absolute Lymphocyte Count in Patients Undergoing Eribulin Treatment for Early Detection of Progressive Advanced or Metastatic Breast Cancer
WATARU GOTO, SHINICHIRO KASHIWAGI, KOJI TAKADA, YUKA ASANO, TAMAMI MORISAKI, MASATSUNE SHIBUTANI, HIROAKI TANAKA, KOSEI HIRAKAWA and MASAICHI OHIRA

Anticancer Research February 2022, 42 (2) 939-946; DOI: https://doi.org/10.21873/anticanres.15553
You have access
Efficacy and Safety of Lenvatinib for Patients With Advanced Hepatocellular Carcinoma: A Retrospective, Real-world Study Conducted in Japan
NAOTAKA SHIMOZATO, TADASHI NAMISAKI, AKIHIRO OKANO, MASAYA OHANA, DAISUKE KINOSHITA, TOSHIHIKO KAWASAKI, YOSUKE AIHARA, TOSHIYA NAKATANI, HIROKI KINOSHITA, TATSUICHI ANN, KO SAITO, MOTOYUKI YOSHIDA and HITOSHI YOSHIJI

Anticancer Research January 2022, 42 (1) 173-183; DOI: https://doi.org/10.21873/anticanres.15471
You have access
Correlation Between Clinical Outcomes and Serum CA-125 Levels After Standard Treatment for Epithelial Ovarian Cancer
JUHUN LEE, JONG MI KIM, YOON HEE LEE, GUN OH CHONG and DAE GY HONG

Anticancer Research January 2022, 42 (1) 349-353; DOI: https://doi.org/10.21873/anticanres.15492
You have access
Effects of Circulating 25(OH)D Status in Advanced Colorectal Cancer Patients Undergoing Chemotherapy: A Systematic Review
XIAOFENG ZENG, LIYING ZHANG, SHULI JIA, TAIPING LIN, GONGXIANG LIU, JIRONG YUE and XIAOLI HUANG

Anticancer Research December 2021, 41 (12) 5903-5912; DOI: https://doi.org/10.21873/anticanres.15409

Main menu

User menu

Search

progression-free survival

Pages